Global 4-AA API Market Growth 2024-2030

Publication ID:

LPI07241025

Publication Date:

July 5, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

4-AA, CAS number: 76855-69-1, chemical name: (3S,4R)-4-Acetoxy-3-[(R)-1-(tert-butyldimethylsilyloxy)ethyl]azetidin-2-one. It is a key intermediate for the synthesis of penem drugs.
The global 4-AA API market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥�4-AA API Industry Forecast鈥� looks at past sales and reviews total world 4-AA API sales in 2023, providing a comprehensive analysis by region and market sector of projected 4-AA API sales for 2024 through 2030. With 4-AA API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world 4-AA API industry.
This Insight Report provides a comprehensive analysis of the global 4-AA API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on 4-AA API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global 4-AA API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for 4-AA API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global 4-AA API.
United States market for 4-AA API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for 4-AA API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for 4-AA API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key 4-AA API players cover Zhejiang Hisoar Pharmaceutical, Zhejiang Jiuzhou Pharmaceutical, Jiangxi Fushine Pharmaceutical, Sichuan Xindi Pharmaceutical, Shandong Jincheng Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of 4-AA API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
99% Purity
99.5% Purity
Segmentation by Application:
Meropenem
Imipenem
Biapenem
Ertapenem
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Zhejiang Hisoar Pharmaceutical
Zhejiang Jiuzhou Pharmaceutical
Jiangxi Fushine Pharmaceutical
Sichuan Xindi Pharmaceutical
Shandong Jincheng Pharmaceutical
Xinxiang Haibin Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global 4-AA API market?
What factors are driving 4-AA API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do 4-AA API market opportunities vary by end market size?
How does 4-AA API break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global 4-AA API Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for 4-AA API by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for 4-AA API by Country/Region, 2019, 2023 & 2030
2.2 4-AA API Segment by Type
2.2.1 99% Purity
2.2.2 99.5% Purity
2.3 4-AA API Sales by Type
2.3.1 Global 4-AA API Sales Market Share by Type (2019-2024)
2.3.2 Global 4-AA API Revenue and Market Share by Type (2019-2024)
2.3.3 Global 4-AA API Sale Price by Type (2019-2024)
2.4 4-AA API Segment by Application
2.4.1 Meropenem
2.4.2 Imipenem
2.4.3 Biapenem
2.4.4 Ertapenem
2.4.5 Others
2.5 4-AA API Sales by Application
2.5.1 Global 4-AA API Sale Market Share by Application (2019-2024)
2.5.2 Global 4-AA API Revenue and Market Share by Application (2019-2024)
2.5.3 Global 4-AA API Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global 4-AA API Breakdown Data by Company
3.1.1 Global 4-AA API Annual Sales by Company (2019-2024)
3.1.2 Global 4-AA API Sales Market Share by Company (2019-2024)
3.2 Global 4-AA API Annual Revenue by Company (2019-2024)
3.2.1 Global 4-AA API Revenue by Company (2019-2024)
3.2.2 Global 4-AA API Revenue Market Share by Company (2019-2024)
3.3 Global 4-AA API Sale Price by Company
3.4 Key Manufacturers 4-AA API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers 4-AA API Product Location Distribution
3.4.2 Players 4-AA API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for 4-AA API by Geographic Region
4.1 World Historic 4-AA API Market Size by Geographic Region (2019-2024)
4.1.1 Global 4-AA API Annual Sales by Geographic Region (2019-2024)
4.1.2 Global 4-AA API Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic 4-AA API Market Size by Country/Region (2019-2024)
4.2.1 Global 4-AA API Annual Sales by Country/Region (2019-2024)
4.2.2 Global 4-AA API Annual Revenue by Country/Region (2019-2024)
4.3 Americas 4-AA API Sales Growth
4.4 APAC 4-AA API Sales Growth
4.5 Europe 4-AA API Sales Growth
4.6 Middle East & Africa 4-AA API Sales Growth
5 Americas
5.1 Americas 4-AA API Sales by Country
5.1.1 Americas 4-AA API Sales by Country (2019-2024)
5.1.2 Americas 4-AA API Revenue by Country (2019-2024)
5.2 Americas 4-AA API Sales by Type (2019-2024)
5.3 Americas 4-AA API Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC 4-AA API Sales by Region
6.1.1 APAC 4-AA API Sales by Region (2019-2024)
6.1.2 APAC 4-AA API Revenue by Region (2019-2024)
6.2 APAC 4-AA API Sales by Type (2019-2024)
6.3 APAC 4-AA API Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe 4-AA API by Country
7.1.1 Europe 4-AA API Sales by Country (2019-2024)
7.1.2 Europe 4-AA API Revenue by Country (2019-2024)
7.2 Europe 4-AA API Sales by Type (2019-2024)
7.3 Europe 4-AA API Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa 4-AA API by Country
8.1.1 Middle East & Africa 4-AA API Sales by Country (2019-2024)
8.1.2 Middle East & Africa 4-AA API Revenue by Country (2019-2024)
8.2 Middle East & Africa 4-AA API Sales by Type (2019-2024)
8.3 Middle East & Africa 4-AA API Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of 4-AA API
10.3 Manufacturing Process Analysis of 4-AA API
10.4 Industry Chain Structure of 4-AA API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 4-AA API Distributors
11.3 4-AA API Customer
12 World Forecast Review for 4-AA API by Geographic Region
12.1 Global 4-AA API Market Size Forecast by Region
12.1.1 Global 4-AA API Forecast by Region (2025-2030)
12.1.2 Global 4-AA API Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global 4-AA API Forecast by Type (2025-2030)
12.7 Global 4-AA API Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Zhejiang Hisoar Pharmaceutical
13.1.1 Zhejiang Hisoar Pharmaceutical Company Information
13.1.2 Zhejiang Hisoar Pharmaceutical 4-AA API Product Portfolios and Specifications
13.1.3 Zhejiang Hisoar Pharmaceutical 4-AA API Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Zhejiang Hisoar Pharmaceutical Main Business Overview
13.1.5 Zhejiang Hisoar Pharmaceutical Latest Developments
13.2 Zhejiang Jiuzhou Pharmaceutical
13.2.1 Zhejiang Jiuzhou Pharmaceutical Company Information
13.2.2 Zhejiang Jiuzhou Pharmaceutical 4-AA API Product Portfolios and Specifications
13.2.3 Zhejiang Jiuzhou Pharmaceutical 4-AA API Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Zhejiang Jiuzhou Pharmaceutical Main Business Overview
13.2.5 Zhejiang Jiuzhou Pharmaceutical Latest Developments
13.3 Jiangxi Fushine Pharmaceutical
13.3.1 Jiangxi Fushine Pharmaceutical Company Information
13.3.2 Jiangxi Fushine Pharmaceutical 4-AA API Product Portfolios and Specifications
13.3.3 Jiangxi Fushine Pharmaceutical 4-AA API Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Jiangxi Fushine Pharmaceutical Main Business Overview
13.3.5 Jiangxi Fushine Pharmaceutical Latest Developments
13.4 Sichuan Xindi Pharmaceutical
13.4.1 Sichuan Xindi Pharmaceutical Company Information
13.4.2 Sichuan Xindi Pharmaceutical 4-AA API Product Portfolios and Specifications
13.4.3 Sichuan Xindi Pharmaceutical 4-AA API Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Sichuan Xindi Pharmaceutical Main Business Overview
13.4.5 Sichuan Xindi Pharmaceutical Latest Developments
13.5 Shandong Jincheng Pharmaceutical
13.5.1 Shandong Jincheng Pharmaceutical Company Information
13.5.2 Shandong Jincheng Pharmaceutical 4-AA API Product Portfolios and Specifications
13.5.3 Shandong Jincheng Pharmaceutical 4-AA API Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Shandong Jincheng Pharmaceutical Main Business Overview
13.5.5 Shandong Jincheng Pharmaceutical Latest Developments
13.6 Xinxiang Haibin Pharmaceutical
13.6.1 Xinxiang Haibin Pharmaceutical Company Information
13.6.2 Xinxiang Haibin Pharmaceutical 4-AA API Product Portfolios and Specifications
13.6.3 Xinxiang Haibin Pharmaceutical 4-AA API Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Xinxiang Haibin Pharmaceutical Main Business Overview
13.6.5 Xinxiang Haibin Pharmaceutical Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂